INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

TerminatedOBSERVATIONAL
Enrollment

212

Participants

Timeline

Start Date

May 29, 2018

Primary Completion Date

January 15, 2019

Study Completion Date

January 15, 2019

Conditions
Acute Hepatic PorphyriaHepatic PorphyriasAcute Intermittent Porphyria (AIP)Hereditary Coproporphyria (HCP)Variegate Porphyria (VP)ALA Dehydratase Deficient Porphyria (ADP)Porphyria Acute
Trial Locations (12)

11030

Clinical Trial Site, Manhasset

15232

Clinical Trial Site, Pittsburgh

17901

Clinical Trial Site, Pottsville

27103

Clinical Trial Site, Winston-Salem

32256

Clinical Trial Site, Jacksonville

33063

Clinical Trial Site, Margate

37912

Clinical Trial Site, Knoxville

50010

Clinical Trial Site, Ames

77025

Clinical Trial Site, Houston

84124

Clinical Trial Site, Salt Lake City

89106

Clinical Trial Site, Las Vegas

91101

Clinical Trial Site, Pasadena

Sponsors
All Listed Sponsors
lead

Alnylam Pharmaceuticals

INDUSTRY